Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H, Feuerhake F, Kutok JL, Monti S, Dal Cin P, Neuberg D, Aster JC, Shipp MA. Takahashi H, et al. Among authors: kutok jl. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3265-71. doi: 10.1158/1078-0432.CCR-06-0076. Clin Cancer Res. 2006. PMID: 16740746
MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.
Juszczynski P, Rodig SJ, Ouyang J, O'Donnell E, Takeyama K, Mlynarski W, Mycko K, Szczepanski T, Gaworczyk A, Krivtsov A, Faber J, Sinha AU, Rabinovich GA, Armstrong SA, Kutok JL, Shipp MA. Juszczynski P, et al. Among authors: kutok jl. Clin Cancer Res. 2010 Apr 1;16(7):2122-30. doi: 10.1158/1078-0432.CCR-09-2765. Epub 2010 Mar 23. Clin Cancer Res. 2010. PMID: 20332322 Free PMC article.
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Green MR, Monti S, Rodig SJ, Juszczynski P, Currie T, O'Donnell E, Chapuy B, Takeyama K, Neuberg D, Golub TR, Kutok JL, Shipp MA. Green MR, et al. Among authors: kutok jl. Blood. 2010 Oct 28;116(17):3268-77. doi: 10.1182/blood-2010-05-282780. Epub 2010 Jul 13. Blood. 2010. PMID: 20628145 Free PMC article.
Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas.
Kondratiev S, Duraisamy S, Unitt CL, Green MR, Pinkus GS, Shipp MA, Kutok JL, Drapkin RI, Rodig SJ. Kondratiev S, et al. Among authors: kutok jl. Am J Surg Pathol. 2011 Oct;35(10):1531-9. doi: 10.1097/PAS.0b013e31822bd476. Am J Surg Pathol. 2011. PMID: 21921781 Free PMC article.
Emerging targeted therapies for lymphoid malignancies.
Pozdnyakova O, Kutok JL, Rodig SJ. Pozdnyakova O, et al. Among authors: kutok jl. Arch Pathol Lab Med. 2012 May;136(5):476-82. doi: 10.5858/arpa.2010-0391-RA. Epub 2011 Dec 21. Arch Pathol Lab Med. 2012. PMID: 22188200 Free article. Review.
202 results